Skip to content
2000
Volume 29, Issue 21
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

This article explores the significant impact of artificial intelligence (AI) and machine learning (ML) on the pharmaceutical industry, which has transformed the drug development process. AI and ML technologies provide powerful tools for analysis, decision-making, and prediction by simplifying complex procedures from drug design to formulation design. These techniques could potentially speed up the development of better medications and drug development processes, improving the lives of millions of people. However, the use of these techniques requires trained personnel and human surveillance for AI to function effectively, if not there is a possibility of errors like security breaches of personal data and bias can also occur. Thus, the present review article discusses the transformative power of AI and ML in the pharmaceutical industry and provides insights into the future of drug development and patient care.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612829666230807161421
2023-06-01
2025-09-04
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612829666230807161421
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test